Metabolic
SLU-PP-332
A synthetic small-molecule pan-agonist of the estrogen-related receptors (ERRα, ERRβ, ERRγ), not a peptide.
Also known as SLU PP 332 · ERR agonist · exercise mimetic
NO HUMAN DATA
No human trial has ever been published for this compound. The dose, the frequency and the cycle length on this page describe what unregulated users report doing. They are not findings.
No human trials, no human pharmacokinetics, no human safety data, no published human dosing. The range shown is half a tablet to one tablet of vendor packaging.
At a glance
Dose summary
No reliable human half-life has been published for SLU-PP-332, so none is listed rather than guessed at.
No regulator and no trial set these numbers. They describe what people actually do, recorded so you can see the range rather than guess at it — which is not the same thing as a recommendation.
Form
Nothing to reconstitute
SLU-PP-332 is taken by mouth, not injected, so there is no vial, no diluent and no draw volume. The typical dose is 1 mg per administration — that is the number on the capsule or tablet, and the reconstitution calculator deliberately excludes this compound.
Mechanism & evidence
What it is, and what is known
A synthetic small-molecule pan-agonist of the estrogen-related receptors (ERRα, ERRβ, ERRγ), not a peptide. It is marketed as an "exercise mimetic" because in mice it increased oxidative metabolism, running endurance and fat oxidation and reduced fat gain on a high-fat diet without changing food intake. That is the entire evidence base: preclinical rodent and cell work from academic labs. There are NO human trials, no human pharmacokinetics, no human safety data and no published human dosing whatsoever — nothing here is derived from a study in people.
It is sold as 1 mg oral tablets, so the 500-1000 mcg (0.5-1 mg) daily range shown is simply half a tablet to one tablet: a deliberately narrow, conservative reading of vendor packaging, not a validated dose. Human half-life is unknown, so it is left null rather than guessed. It is swallowed as tablets rather than reconstituted, so the reconstitution fields do not apply. Treat every number on this page as the lowest possible confidence.
Tolerability
Reported side effects
- Unknown in humans — no clinical safety data of any kind exists
- Stimulant-like restlessness or insomnia reported anecdotally, not in any trial
- Elevated heart rate reported anecdotally
- Rodent studies used doses far above anything sold to consumers, so the animal safety record does not translate to human tablets
Hard stops
Do not use this if
- Pregnancy, possible pregnancy, or breastfeeding
- Under 18
These are flags, not a screening. They do not replace a conversation with a clinician who knows your history.
Handling
Storage
Keep it cold, dry and dark. The figures above are shelf-life conventions, not stability testing on the product you bought.
Combinations
Commonly stacked with
Stacking multiplies the side-effect surface and makes it impossible to tell which compound did what. Add one thing at a time.
References
Sources
Educational information only, not medical advice. Talk to a licensed clinician before starting, changing, or stopping anything.